65,437 trials
Aspergillosis; Pulmonary, Invasive (Etiology)
Primary: Number of Participants With IAA-infection at ICU Discharge — 2; 4 Participants
Kidney Transplant; Complications · Toxicity · Drug Toxicity
Primary: Change in Neurocognitive Side Effects — 1.2; 0.2; 1.0; 1.26 score on a scale
Posttraumatic Stress Disorder
Primary: Change From Baseline in Clinician-Administered PTSD Scale at 8 Weeks — 38.6; 26.9 score on a scale
PTSD
Primary: Number and Percentage of Participants That Attend All Offered Cognitive Processing Therapy Sessions — 31; 32 Participants
Rotator Cuff Tears
Primary: Patient-Reported Outcomes Measurement Information System (PROMIS) - Physical Function Short Form — 41.51; 40.54; 36.81; 32.16 T-Score
Advanced Solid Tumors
Primary: Percentage of Participants With ≥1 Dose Limiting Toxicity (DLT) — 0.0; 13.3; 0.0; 7.5 Percentage of Participants
Dry Eye
Primary: SANDE Questionnaire — -7.2; -2.2 score
Cervical Intraepithelial Neoplasia
Primary: Proportion of Participants With Residual CIN2+ — 18; 29; 25 Participants
Diabetes Mellitus, Type 2
Primary: Diabetes Distress - Change in Patient Reported Outcomes (PROs) — 1.9; 1.9 score on a scale — p=0.04
Coronary Heart Disease
Primary: Difference Between Measurements of Myocardial Blood Flow Measured With PET and With SPECT — 0.06 mean residual difference in MBF
End Stage Renal Disease · Renal Impairment
Primary: Area Under the Plasma Concentration Time Curve of Belzutifan From Hour 0 to Infinity (AUC0-inf) — 17100; 21100; 18500 ng•hr/mL
Tobacco Use Cessation
Primary: Adherence to NRT — 47.4; 32.7 days of NRT use
Lymphoma, B-Cell
Primary: Objective Response Rate (ORR) Using International Working Group (IWG) Revised Response Criteria for Malignant Lymphoma as Assessed by Independent Central Review — 42.9…
Myopia
Primary: Percentage of Eyes With Uncorrected Distance Visual Acuity (UCDVA) of 20/40 or Better (in Eyes With Preoperative Best Corrected Distance Visual Acuity (BCDVA) of 20/20…
Rheumatoid Arthritis
Primary: CUDOS Score: Baseline (Visit 1) and 12 Months (Visit 3) — 21.97; 9.29 Units on a scale — p=<0.001